TrialArteriosclerosis, thrombosis, and vascular biology2023

Novel Tissue Factor Inhibition for Thromboprophylaxis in COVID-19: Primary Results of the ASPEN-COVID-19 Trial.

Connie N Hess et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.